The Latest in Immuno-oncology

Oncology Practice

Sequential CRT, immunotherapy nets high PFS in node-positive cervical cancer

December 2, 2019

Hematology News

ASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTE

November 26, 2019

Oncology Practice

Combo elicits lasting responses in metastatic melanoma

November 25, 2019

Oncology Practice

Atezolizumab/bevacizumab may offer benefit to patients with RCC

November 25, 2019

Oncology Practice

Neoantigen vaccine appears safe and active in NSCLC

November 14, 2019

Oncology Practice

Combo produces disappointing PFS, promising OS in metastatic colorectal cancer

November 13, 2019

Hematology News

Armored CAR T cells elicit responses in NHL patients

November 12, 2019

Oncology Practice

Combo shows promise for checkpoint inhibitor-refractory urothelial carcinoma

November 12, 2019

Oncology Practice

TLR9 agonist may overcome resistance to anti–PD-1 therapy in melanoma

November 12, 2019

Oncology Practice

Molecule exhibits activity in heavily pretreated, HER2-positive solid tumors

November 11, 2019

Oncology Practice

Tumor surroundings may hold key to TNBC treatment optimization

November 8, 2019

Oncology Practice

Better overall survival with nivolumab vs. chemo for advanced ESCC

November 7, 2019

Oncology Practice

Nivolumab benefit for NSCLC persists at 5-year follow-up

November 6, 2019

Oncology Practice

Immune checkpoint inhibition in SCLC: Modest outcomes, many questions

November 4, 2019

Oncology Practice

New data further define role of PD-L1 status, immunotherapy in metastatic breast cancer

October 31, 2019